Current Report Filing (8-k)
13 December 2022 - 12:01AM
Edgar (US Regulatory)
0000720154
false
0000720154
2022-12-12
2022-12-12
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
December 12, 2022
INOTIV, INC. |
(Exact name of registrant as specified in its charter) |
Indiana |
|
0-23357 |
|
35-1345024 |
(State or other jurisdiction of
incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
2701 KENT AVENUE
WEST LAFAYETTE, indiana |
|
47906-1382 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant's telephone number, including area code: (765) 463-4527
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title
of each class |
Trading Symbol(s) |
Name of each
exchange
on which registered |
Common Shares |
NOTV |
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company ¨
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02. |
Results of Operations and Financial Condition |
On December 12, 2022, Inotiv, Inc. (the “Company”) issued a press release announcing a delay of the release of its full financial results and quarterly conference call, providing select preliminary unaudited financial results for the fiscal year ended September 30, 2022, and providing a business update. The full text of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
The information provided in Item 2.02 and Item
9.01, including Exhibit 99.1, of this Form 8-K is being furnished and shall not be deemed "filed" for the purpose of Section
18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that
section and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of
1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as
shall be expressly set forth by specific reference in such a filing.
Item 9.01. |
Financial Statements and Exhibits. |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
INOTIV, INC. |
|
|
|
Date: December 12, 2022 |
By: |
/s/ Beth A. Taylor |
|
|
Chief Financial Officer, |
|
|
Vice President—Finance |
Bioanalytical Systems (NASDAQ:BASI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bioanalytical Systems (NASDAQ:BASI)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Bioanalytical Systems Inc (NASDAQ): 0 recent articles
More Inotiv, Inc. News Articles